Advancements in antibody technologies and protein data are driving new possibilities in cancer research, enabling the identification of novel biomarkers and enhancing therapeutic strategies. In this ...

raising $128m through a Series A financing round for its new approach to discovering and developing agonist antibodies. BVF Partners and Atlas Venture jointly led the financing round with ...

VUMC has been awarded up to $30 million from the Advanced Research Projects Agency for Health (ARPA-H) to build a massive antibody-antigen atlas, develop AI-based algorithms to engineer ...